glp-1 news 2025 november ISPOR 2025: Exploring reasons for GLP-1 discontinuation GLP-1 Weight-Loss Drug Demonstration Begins

You will also receive guidance on nutrition and lifestyle to help minimize tiredness

Whilst changes in urine smell are not listed amongst the common adverse effects of Wegovywhich include nausea, diarrhoea, vomiting, constipation, and abdominal painindividual experiences can vary

Clinical trial data shows substantial AHI reductions and improved blood oxygen saturation, with apnea improvements correlating strongly with the degree of weight loss (ref)

Our process includes the following steps: During your initial consultation, our healthcare providers will review your medical history, current medications, and any underlying health conditions

By month three, you are typically at or approaching the maintenance dose